Roadmaps to the Intertwined IP and Regulatory Regimes in China

May 13, 2020 9:00 AM to 10:00 AM

Location

Virtual - all times are eastern daylight time

Credits

60 Minutes of MCLE

Moderator: Jeremy K. McKown, Janssen R&D, New Brunswick, NJ

Topics

Developments in pharmaceutical IP and regulatory coordination efforts to stimulate faster and better pharmaceutical development in China
Juhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China

Using Patent Law and Policy for Incentivizing Green Technology Innovation in China
Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China

Presented by the IP Practice in China Committee and the US Group of AIPPI

Speakers

Luo, Juhua
CCPIT Patent and Trademark Law Office

Mr. Luo's practice focuses mainly on prosecution of patent.
McKown, Jeremy K.
Janssen R&D at Johnson & Johnson | Vice President of Law

Jeremy is a Vice-President at Janssen R&D, a Johnson & Johnson affiliate (J&J), where he manages a global team of attorneys and professionals focused on drafting and negotiating complex agreements related to J&J's pharmaceutical business.
Cao, Wen
Shanghai Office of NTD | Senior Partner

Ms. Cao serves as the principal of NTD Shanghai Office.